Links are not yet activated.
To activate, add a link back to submitpr.org from your website and contact @jaycosta on Telegram,
or pay via Solana (from $19.95) for instant activation.
Eli Lilly made history on April 1, 2026, when the FDA approved **Foundayo™ (orforglipron)** — a once-daily oral GLP-1 weight loss pill that can be taken any time of day, without food or water restrictions. It's the fastest approval of a new molecular entity since 2002, and it could reshape who gets access to weight-loss medication in America.::alert info
FDA approved Foundayo (orforglipron) on April 1, 2026 — prescriptions are being accepted immediately, with shipping starting April 6, 2026.
::end
## What Is Foundayo (Orforglipron)?
Foundayo is a **small-molecule, non-peptide GLP-1 receptor agonist** developed by Eli Lilly. Unlike semaglutide (the ingredient in Ozempic and Wegovy), orforglipron isn't a peptide — it's a small synthetic molecule that binds to the GLP-1 receptor through an allosteric mechanism, triggering the same weight-loss and blood-sugar effects without the need for injections or rigid dosing windows.
The FDA approved it for adults with:
- **Obesity** (BMI ≥ 30), or
- **Overweight** (BMI ≥ 27) with at least one weight-related condition (hypertension, type 2 diabetes, high cholesterol, etc.)
It's meant to be used alongside a reduced-calorie diet and increased physical activity — same as every other GLP-1 on the market.
## How Foundayo Compares to Ozempic and Wegovy
::versus
**Foundayo (Orforglipron)**
- Oral pill, taken any time of day
- No food or water restrictions
- Small molecule — room-temperature stable
- 12.4% average weight loss at highest dose
- $149/month self-pay (lowest dose)
vs
**Ozempic / Wegovy (Semaglutide)**
- Injectable (weekly) or oral (empty stomach required)
- Oral Wegovy requires strict timing with water
- Peptide-based — requires refrigeration
- ~15–17% weight loss (Wegovy)
- $149–199/month self-pay (oral, intro pricing)
::end
The biggest differentiator isn't the weight loss — it's the **convenience**. You can take Foundayo with your morning coffee, after dinner, or whenever works. Oral Wegovy and oral semaglutide require a 30-minute fasting window with exactly 4 oz of water. For millions of people, that small friction is the difference between staying on medication and quitting.
## Clinical Trial Results: How Well Does It Work?
For full coverage, visit https://www.linos.ai/health/foundayo-orforglipron-fda-approved-2026/
About Linos NEWS: Linos NEWS (https://www.linos.ai) delivers breaking news and in-depth analysis across politics, technology, business, science, health, world affairs, sports, and entertainment.